이탈리아 -
이탈리아어 -
Ministero della Salute
sapheon venaseal system
sapheon, inc - dispositivi per sistema artero-venoso - altri
유럽 연합 -
이탈리아어 -
EMA (European Medicines Agency)
bevespi aerosphere
astrazeneca ab - glycopyrronium, formoterol fumarate dihydrate - malattia polmonare, ostruttiva cronica - formoterolo e glycopyrronium bromuro - bevespi aerosphere è indicato come un broncodilatatore di mantenimento di trattamento per alleviare i sintomi in pazienti adulti con malattia polmonare ostruttiva cronica (bpco).
유럽 연합 -
이탈리아어 -
EMA (European Medicines Agency)
trixeo aerosphere
astrazeneca ab - formoterol fumarate dihydrate, glycopyrronium bromide, budesonide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - trixeo aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long acting beta2 agonist or combination of a long-acting beta2 agonist and a long acting muscarinic antagonist.
유럽 연합 -
이탈리아어 -
EMA (European Medicines Agency)
riltrava aerosphere
astrazeneca ab - budesonide, formoterol fumarate dihydrate, glycopyrronium bromide - malattia polmonare, ostruttiva cronica - farmaci per le malattie respiratorie ostruttive, - riltrava aerosphere is indicated as a maintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2 agonist or combination of a long-acting beta2 agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5.
유럽 연합 -
이탈리아어 -
EMA (European Medicines Agency)
dimethyl fumarate neuraxpharm
laboratorios lesvi s.l. - dimetilfumarato - sclerosi multipla recidivante-remittente - immunosoppressori - dimethyl fumarate neuraxpharma is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis.
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
methylphenidat sandoz 18 retardtabletten
sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 18 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
methylphenidat sandoz 36 retardtabletten
sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 36 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
methylphenidat sandoz 54 retardtabletten
sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 54 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika
스위스 -
이탈리아어 -
Swissmedic (Swiss Agency for Therapeutic Products)
methylphenidat sandoz 27 retardtabletten
sandoz pharmaceuticals ag - methylphenidati hydrochloridum - retardtabletten - methylphenidati hydrochloridum 27 mg, antiox.: e 321, excipiens pro compresso haze. - zentralnervöses stimolante - synthetika